5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Update on Early Stage NSCLC: Role of Screening, Neoadjuvant Therapies (Immune Checkpoint Inhibitors, Neo Chemo/IO) & Durvalumab in Surgically Unresectable Stage III
Comments 0
Login to view comments.
Click here to Login
